Women who were prescribed menopausal hormone therapy had modestly reduced risk for all-cause mortality vs. those who did not receive a prescription, according to data published in The BMJ.

Women who begin using menopausal hormone therapy at age 65 years or older may have higher risk for cancer and cardiovascular events than those who never use HT, according to data published in ...

HT-001 demonstrated significant efficacy in reducing skin toxicities from EGFR inhibitors, achieving primary endpoints in all patients. Patients experienced improved quality of life, with 66% ...

Women who used transdermal hormone therapy (HT) to treat menopausal symptoms experienced lower rates of anxiety and depression than those who used oral HT, found a study presented at The Menopause ...